Urothelial-Cell Carcinoma and Solitary Kidney: Outcomes with Renal-Sparing Management

Milner, John; Voelzke, Bryan B.; Flanigan, Robert C.; Sharma, SK; Perry, Kent T.; Türk, Thomas

doi:10.1089/end.2006.20.800

Cited by 7 publications

(8 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[12][13][14][15][16][17] Cancer-specific survival rates ranged from 49.3% to 100% in the selected series. Renal preservation rates ranged from 70% to 80%.…”

Section: Survival Analysismentioning

confidence: 98%

What Is the Cost of Maintaining a Kidney in Upper-Tract Transitional-Cell Carcinoma? An Objective Analysis of Cost and Survival

Pak

Moskowitz

Bagley

2009

Journal of Endourology

View full text Add to dashboard Cite

“…[12][13][14][15][16][17] Cancer-specific survival rates ranged from 49.3% to 100% in the selected series. Renal preservation rates ranged from 70% to 80%.…”

Section: Survival Analysismentioning

confidence: 98%

What Is the Cost of Maintaining a Kidney in Upper-Tract Transitional-Cell Carcinoma? An Objective Analysis of Cost and Survival

Pak

Moskowitz

Bagley

2009

Journal of Endourology

View full text Add to dashboard Cite

“…Milner and colleagues reported on the percutaneous management of low-grade tumours in a solitary kidney and concluded that in motivated patients, who would adhere to strict follow-up regimens, this was a viable option. 4 Looking at this from a cost analysis perspective, Pak and colleagues concluded that renal-sparing upper urinary tract TCC management was effective at reducing healthcare expenses related to end-stage renal disease. 4 Our patient was unique in that the tumour was unmanageable endoscopically, but the option of radical nephroureterectomy would render him anephric.…”

Section: Discussionmentioning

confidence: 99%

“…4 Looking at this from a cost analysis perspective, Pak and colleagues concluded that renal-sparing upper urinary tract TCC management was effective at reducing healthcare expenses related to end-stage renal disease. 4 Our patient was unique in that the tumour was unmanageable endoscopically, but the option of radical nephroureterectomy would render him anephric. Had the tumour been a smaller, non-circumferential lesion, involving the …”

Section: Discussionmentioning

confidence: 99%

Total ureterectomy and ileal ureteric replacement for TCC ureter in a solitary kidney

Banerji

George

2014

CUAJ

View full text Add to dashboard Cite

Cite as: Can Urol Assoc J 2014;8(11-12) AbstractTraditional treatment of upper tract transitional cell carcinoma (TCC) is nephroureterectomy with a bladder cuff. This is in keeping with the nature of the disease, in that TCC is a panurothelial disease. However, there are a few rare occasions when this would mean making a subject anephric, as in a TCC in a solitary kidney or bilateral synchronous/metachronous disease. We present a case of a patient with a dysplastic, poorly functioning left kidney and with a TCC of the ureter on the right side.

show abstract

“…Electrocautery, neodymium:yttrium-aluminium-garnet laser, and holmium laser are all feasible energy sources, with laser ablation preferred by many contemporary practitioners. The patient should be forewarned that complete eradication of lesions may not be accomplished on the initial intervention and that recurrences are common [7]. While this is an upper-pole lesion, the approach can also be percutaneous, although a concern for tumor along the access tract does exist.…”

Section: Expert Commentary: Dr Malkowiczmentioning

confidence: 99%

A 79-year-old man with urothelial carcinoma of the bladder and upper urinary tract

Soloway

2007

Curr Urol Rep

View full text Add to dashboard Cite

A 79-year-old man in generally good health was initially seen in consultation in December 1999. He had a 5-year history of low-grade Ta bladder tumors. He then developed right flank pain. His urologist performed a CT scan of the abdomen and pelvis and right hydronephrosis was found. A retrograde scan indicated two small filling defects in the mid and lower ureter. A double-J stent placed after a diagnostic ureteroscopy identified two papillary tumors. His left upper tract was normal and his bladder was free of tumor at that time.The patient's history was pertinent for gastric cancer treated several years earlier with surgery and chemotherapy. There had been no recurrence. His physical examination findings were normal, and he had never smoked cigarettes. A subsequent ureteroscopy showed significant reaction in the ureter. Several papillary tumors were identified. A nephroureterectomy was performed in February 2000. Pathologic analysis revealed low-grade Ta tumors in the lower ureter and low and focal high-grade urothelial cancer in the renal pelvis and calyces. The highgrade tumor extended into the muscularis of the upper ureter and the fat. Surgical margins were free. No adjuvant therapy was given. During the subsequent 7 years he has had papillary tumors of the bladder, mostly low-grade Ta, but recently he has had high-grade Ta tumors treated by endoscopic resection and bacillus Calmette-Guérin (BCG). He has had three 6-week courses of BCG over the intervening years. Now, however, he has papillary tumors in the very distal left ureter and a papillary lesion in the upper pole infundibulum of the solitary left kidney.A biopsy of the renal lesion revealed a papillary low and focally high-grade tumor without obvious invasion. The patient has a creatinine level of 1.8. He has no acute cardiac or respiratory complaints.

show abstract

Urothelial-Cell Carcinoma and Solitary Kidney: Outcomes with Renal-Sparing Management

Cited by 7 publications

References 12 publications

What Is the Cost of Maintaining a Kidney in Upper-Tract Transitional-Cell Carcinoma? An Objective Analysis of Cost and Survival

What Is the Cost of Maintaining a Kidney in Upper-Tract Transitional-Cell Carcinoma? An Objective Analysis of Cost and Survival

Total ureterectomy and ileal ureteric replacement for TCC ureter in a solitary kidney

A 79-year-old man with urothelial carcinoma of the bladder and upper urinary tract

Contact Info

Product

Resources

About